Skip to main content
PMC home page
Quality & Safety in Health Care logoLink to Quality & Safety in Health Care
. 2004 Jun;13(3):191–197. doi: 10.1136/qshc.2003.007401

Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK

P McElduff 1, G Lyratzopoulos 1, R Edwards 1, R Heller 1, P Shekelle 1, M Roland 1
PMCID: PMC1743844  PMID: 15175489

Abstract

Objectives: To estimate the total health gain from improving the quality of care among patients with cardiovascular disease in line with the quality indicator targets in the new contract for general practitioners (GPs) in the UK.

Design: Statistical modelling, applying population impact measures to estimate cardiovascular health gains from achieving treatment targets in the GP contract, taking into account current levels of treatment and control.

Main outcome measures: Number of events prevented in the population over 5 years applied to a notional general practice population of 10 000.

Results: The greatest health gain in those aged 45–84 years would come from reaching cholesterol reduction targets. This could prevent 15 events in people with coronary heart disease, seven events in those with a history of stroke, and seven events in those with diabetes. Achieving blood pressure control targets in hypertensive patients without the above conditions could prevent 15 cardiovascular events, with further benefits from reducing blood pressure in patients with high blood pressure and coronary heart disease, stroke, or diabetes. Achieving other targets would have smaller impacts because high levels of care are already being achieved or because of the low prevalence of conditions or associated event risk.

Conclusion: It is possible to quantify the health gain to a practice population of achieving quality targets such as those set in the new GP contract. The amount of health gain is sensitive to current quality of care, prevalence of conditions, and risk factors, and to the size of change anticipated. Nevertheless, it appears that significant health gains could result from achieving the proposed quality targets.

Full Text

The Full Text of this article is available as a PDF (78.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. M., Odell P. M., Wilson P. W., Kannel W. B. Cardiovascular disease risk profiles. Am Heart J. 1991 Jan;121(1 Pt 2):293–298. doi: 10.1016/0002-8703(91)90861-b. [DOI] [PubMed] [Google Scholar]
  2. Brophy J. M., Joseph L., Rouleau J. L. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001 Apr 3;134(7):550–560. doi: 10.7326/0003-4819-134-7-200104030-00008. [DOI] [PubMed] [Google Scholar]
  3. Campbell S. M., Hann M., Hacker J., Burns C., Oliver D., Thapar A., Mead N., Safran D. G., Roland M. O. Identifying predictors of high quality care in English general practice: observational study. BMJ. 2001 Oct 6;323(7316):784–787. doi: 10.1136/bmj.323.7316.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carroll Kevin, Majeed Azeem, Firth Caroline, Gray Jeremy. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register. J Public Health Med. 2003 Mar;25(1):29–35. doi: 10.1093/pubmed/fdg007. [DOI] [PubMed] [Google Scholar]
  5. Chaix-Couturier C., Durand-Zaleski I., Jolly D., Durieux P. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues. Int J Qual Health Care. 2000 Apr;12(2):133–142. doi: 10.1093/intqhc/12.2.133. [DOI] [PubMed] [Google Scholar]
  6. Davies M., Hobbs F., Davis R., Kenkre J., Roalfe A. K., Hare R., Wosornu D., Lancashire R. J. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001 Aug 11;358(9280):439–444. doi: 10.1016/s0140-6736(01)05620-3. [DOI] [PubMed] [Google Scholar]
  7. Edwards R., Burns J. A., McElduff P., Young R. J., New J. P. Variations in process and outcomes of diabetes care by socio-economic status in Salford, UK. Diabetologia. 2003 May 23;46(6):750–759. doi: 10.1007/s00125-003-1102-z. [DOI] [PubMed] [Google Scholar]
  8. Fleming D. M., Watson J. M., Nicholas S., Smith G. E., Swan A. V. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect. 1995 Dec;115(3):581–589. doi: 10.1017/s095026880005874x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fox K. F., Cowie M. R., Wood D. A., Coats A. J., Gibbs J. S., Underwood S. R., Turner R. M., Poole-Wilson P. A., Davies S. W., Sutton G. C. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001 Feb;22(3):228–236. doi: 10.1053/euhj.2000.2289. [DOI] [PubMed] [Google Scholar]
  10. Furukawa Toshiaki A., Guyatt Gordon H., Griffith Lauren E. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol. 2002 Feb;31(1):72–76. doi: 10.1093/ije/31.1.72. [DOI] [PubMed] [Google Scholar]
  11. Gosden T., Forland F., Kristiansen I. S., Sutton M., Leese B., Giuffrida A., Sergison M., Pedersen L. Impact of payment method on behaviour of primary care physicians: a systematic review. J Health Serv Res Policy. 2001 Jan;6(1):44–55. doi: 10.1258/1355819011927198. [DOI] [PubMed] [Google Scholar]
  12. Hak E., Verheij T. J., van Essen G. A., Lafeber A. B., Grobbee D. E., Hoes A. W. Prognostic factors for influenza-associated hospitalization and death during an epidemic. Epidemiol Infect. 2001 Apr;126(2):261–268. doi: 10.1017/s0950268801005180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heller Richard F., Edwards Richard, McElduff Patrick. Implementing guidelines in primary care: can population impact measures help? BMC Public Health. 2003 Jan 23;3:7–7. doi: 10.1186/1471-2458-3-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Law M. R., Wald N. J., Thompson S. G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994 Feb 5;308(6925):367–372. doi: 10.1136/bmj.308.6925.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Law M. R., Wald N. J., Wu T., Hackshaw A., Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ. 1994 Feb 5;308(6925):363–366. doi: 10.1136/bmj.308.6925.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 Mar 31;335(8692):765–774. doi: 10.1016/0140-6736(90)90878-9. [DOI] [PubMed] [Google Scholar]
  17. McAlister Finlay A. Commentary: relative treatment effects are consistent across the spectrum of underlying risks...usually. Int J Epidemiol. 2002 Feb;31(1):76–77. doi: 10.1093/ije/31.1.76. [DOI] [PubMed] [Google Scholar]
  18. Nordin J., Mullooly J., Poblete S., Strikas R., Petrucci R., Wei F., Rush B., Safirstein B., Wheeler D., Nichol K. L. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001 Aug 9;184(6):665–670. doi: 10.1086/323085. [DOI] [PubMed] [Google Scholar]
  19. Pitt B., Zannad F., Remme W. J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999 Sep 2;341(10):709–717. doi: 10.1056/NEJM199909023411001. [DOI] [PubMed] [Google Scholar]
  20. Seddon M. E., Marshall M. N., Campbell S. M., Roland M. O. Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand. Qual Health Care. 2001 Sep;10(3):152–158. doi: 10.1136/qhc.0100152... [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sharma D., Buyse M., Pitt B., Rucinska E. J. Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group. Am J Cardiol. 2000 Jan 15;85(2):187–192. doi: 10.1016/s0002-9149(99)00646-3. [DOI] [PubMed] [Google Scholar]
  22. Sprenger M. J., Mulder P. G., Beyer W. E., Van Strik R., Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol. 1993 Apr;22(2):334–340. doi: 10.1093/ije/22.2.334. [DOI] [PubMed] [Google Scholar]
  23. Thompson William W., Shay David K., Weintraub Eric, Brammer Lynnette, Cox Nancy, Anderson Larry J., Fukuda Keiji. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003 Jan 8;289(2):179–186. doi: 10.1001/jama.289.2.179. [DOI] [PubMed] [Google Scholar]
  24. Vu Trang, Farish Stephen, Jenkins Mark, Kelly Heath. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002 Mar 15;20(13-14):1831–1836. doi: 10.1016/s0264-410x(02)00041-5. [DOI] [PubMed] [Google Scholar]

Articles from Quality & safety in health care are provided here courtesy of BMJ Publishing Group

RESOURCES